STIO Life Science invests EGP 400m to localize Egypt’s pharmaceutical industry
Amr Abdel Razek, Chairperson of STIO Life Science (SLS), announced that the company has invested EGP 400m in the Egyptian market during 2023/2024. These funds have been directed toward development initiatives and securing the necessary business licenses. Abdel Razek highlighted